Shanghai Haohai Biological Technology (6826) Stock Overview
Shanghai Haohai Biological Technology Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
6826 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shanghai Haohai Biological Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$26.12 |
| 52 Week High | HK$34.35 |
| 52 Week Low | HK$21.70 |
| Beta | 0.45 |
| 1 Month Change | -1.21% |
| 3 Month Change | -2.10% |
| 1 Year Change | 4.48% |
| 3 Year Change | -12.73% |
| 5 Year Change | n/a |
| Change since IPO | -42.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6826 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | 2.0% | 6.8% | 1.5% |
| 1Y | 4.5% | 143.0% | 37.5% |
Return vs Industry: 6826 underperformed the Hong Kong Biotechs industry which returned 143% over the past year.
Return vs Market: 6826 underperformed the Hong Kong Market which returned 37.5% over the past year.
Price Volatility
| 6826 volatility | |
|---|---|
| 6826 Average Weekly Movement | 2.9% |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 13.5% |
| 10% least volatile stocks in HK Market | 2.9% |
Stable Share Price: 6826 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6826's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 2,156 | Jianying Wu | www.3healthcare.com |
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop.
Shanghai Haohai Biological Technology Co., Ltd. Fundamentals Summary
| 6826 fundamental statistics | |
|---|---|
| Market cap | HK$10.94b |
| Earnings (TTM) | HK$429.75m |
| Revenue (TTM) | HK$2.80b |
Is 6826 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6826 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.50b |
| Cost of Revenue | CN¥791.69m |
| Gross Profit | CN¥1.71b |
| Other Expenses | CN¥1.33b |
| Earnings | CN¥384.21m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Mar 21, 2026
| Earnings per share (EPS) | 1.70 |
| Gross Margin | 68.38% |
| Net Profit Margin | 15.34% |
| Debt/Equity Ratio | 6.6% |
How did 6826 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/13 01:19 |
| End of Day Share Price | 2026/01/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Haohai Biological Technology Co., Ltd. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaofang Xu | Citic Securities Co., Ltd. |
| Jia'nan Zhao | Citigroup Inc |
| null null | CMB International Securities Limited |